Anastasiadou E, Jacob LS, Slack FJ (2018) Non-coding RNA networks in cancer. Nat Rev Cancer 18(1):5–18. https://doi.org/10.1038/nrc.2017.99

Article  PubMed  Google Scholar 

Calvo F, Sanz-Moreno V, Agudo-Ibáñez L, Wallberg F, Sahai E, Marshall CJ, Crespo P (2011) RasGRF suppresses Cdc42-mediated tumour cell movement, cytoskeletal dynamics and transformation. Nat Cell Biol 13(7):819–826. https://doi.org/10.1038/ncb2271

Article  PubMed  Google Scholar 

Chen H, Xu Z, Yang B, Zhou X, Kong H (2018) RASGRF1 hypermethylation, a putative biomarker of colorectal cancer. Ann Clin Lab Sci 48(1):3–10

PubMed  Google Scholar 

Coan M, Haefliger S, Ounzain S, Johnson R (2024) Targeting and engineering long non-coding RNAs for cancer therapy. Nat Rev Genet. https://doi.org/10.1038/s41576-024-00693-2

Article  PubMed  Google Scholar 

Dedes KJ, Wetterskog D, Ashworth A, Kaye SB, Reis-Filho JS (2011) Emerging therapeutic targets in endometrial cancer. Nat Rev Clin Oncol 8(5):261–271. https://doi.org/10.1038/nrclinonc.2010.216

Article  PubMed  Google Scholar 

Dong P, Xiong Y, Yue J, Hanley SJB, Kobayashi N, Todo Y, Watari H (2018) Long non-coding RNA NEAT1: a novel target for diagnosis and therapy in human tumors. Front Genet 9:471. https://doi.org/10.3389/fgene.2018.00471

Article  PubMed  PubMed Central  Google Scholar 

Dong P, Xiong Y, Yue J, Hanley SJB, Kobayashi N, Todo Y, Watari H (2019) Exploring lncRNA-mediated regulatory networks in endometrial cancer cells and the tumor microenvironment: advances and challenges. Cancers 11(2):234. https://doi.org/10.3390/cancers11020234

Article  PubMed  PubMed Central  Google Scholar 

Font de Mora J, Esteban LM, Burks DJ, Núñez A, Garcés C, García-Barrado MJ, Iglesias-Osma MC, Moratinos J, Ward JM, Santos E (2003) Ras-GRF1 signaling is required for normal beta-cell development and glucose homeostasis. EMBO J 22(12):3039–3049. https://doi.org/10.1093/emboj/cdg280

Article  PubMed  PubMed Central  Google Scholar 

Fu C, Wang S, Jin L, Zhang M, Li M (2021) CircTET1 inhibits retinoblastoma progression via targeting miR-492 and miR-494-3p through Wnt/β-catenin signaling pathway. Curr Eye Res 46(7):978–987. https://doi.org/10.1080/02713683.2020.1843685

Article  PubMed  Google Scholar 

Goodall GJ, Wickramasinghe VO (2021) RNA in cancer. Nat Rev Cancer 21(1):22–36. https://doi.org/10.1038/s41568-020-00306-0

Article  PubMed  Google Scholar 

Han B (2019) LncRNA LINC02418 regulates proliferation and apoptosis of non-small cell lung cancer cells by regulating miR-4677-3p/SEC61G. Eur Rev Med Pharmacol Sci 23(23):10354–10362. https://doi.org/10.26355/eurrev_201912_19673

Article  PubMed  Google Scholar 

Hombach S, Kretz M (2016) Non-coding RNAs: classification, biology and functioning. Adv Exp Med Biol 937:3–17. https://doi.org/10.1007/978-3-319-42059-2_1

Article  PubMed  Google Scholar 

Izzotti A (2024) MicroRNA and cancer: a path to discovery. Microrna 13(1):1. https://doi.org/10.2174/221153661301240226102741

Article  PubMed  Google Scholar 

Kim O, Tran PT, Gal M, Lee SJ, Na SH, Hwangbo C, Lee JH (2023) RAS-stimulated release of exosomal miR-494-3p promotes the osteolytic bone metastasis of breast cancer cells. Int J Mol Med 52(3):84. https://doi.org/10.3892/ijmm.2023.5287

Article  PubMed  PubMed Central  Google Scholar 

Li R, Gao X, Sun H, Sun L, Hu X (2022) Expression characteristics of long non-coding RNA in colon adenocarcinoma and its potential value for judging the survival and prognosis of patients: bioinformatics analysis based on The Cancer Genome Atlas database. J Gastrointest Oncol 13(3):1178–1187. https://doi.org/10.21037/jgo-22-384

Article  PubMed  PubMed Central  Google Scholar 

Meng X, Li A, Yu B, Li S (2021) Interplay between miRNAs and lncRNAs: mode of action and biological roles in plant development and stress adaptation. Comput Struct Biotechnol J 19:2567–2574. https://doi.org/10.1016/j.csbj.2021.04.062

Article  PubMed  PubMed Central  Google Scholar 

Mikhailov AT, Torrado M (2018) Interplay between cardiac transcription factors and non-coding RNAs in predisposing to atrial fibrillation. J Mol Med 96(7):601–610. https://doi.org/10.1007/s00109-018-1647-4

Article  PubMed  Google Scholar 

Nemeth K, Bayraktar R, Ferracin M, Calin GA (2024) Non-coding RNAs in disease: from mechanisms to therapeutics. Nat Rev Genet 25(3):211–232. https://doi.org/10.1038/s41576-023-00662-1

Article  PubMed  Google Scholar 

Rong D, Sun G, Wu F, Cheng Y, Sun G, Jiang W, Li X, Zhong Y, Wu L, Zhang C, Tang W, Wang X (2021) Epigenetics: roles and therapeutic implications of non-coding RNA modifications in human cancers. Mol Ther Nucleic Acids 25:67–82. https://doi.org/10.1016/j.omtn.2021.04.021

Article  PubMed  PubMed Central  Google Scholar 

Shang R, Lee S, Senavirathne G, Lai EC (2023) microRNAs in action: biogenesis, function and regulation. Nat Rev Genet 24(12):816–833. https://doi.org/10.1038/s41576-023-00611-y

Article  PubMed  PubMed Central  Google Scholar 

Shetty A, Venkatesh T, Kabbekodu SP, Tsutsumi R, Suresh PS (2022) LncRNA-miRNA-mRNA regulatory axes in endometrial cancer: a comprehensive overview. Arch Gynecol Obstet 306(5):1431–1447. https://doi.org/10.1007/s00404-022-06423-5

Article  PubMed  Google Scholar 

Sun Z, Mai H, Xue C, Fan Z, Li J, Chen H, Huo N, Kang X, Tang C, Fang L, Zhao H, Han Y, Sun C, Peng H, Du Y, Yang J, Du N, Xu X (2023) Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitination. J Immunother Cancer 11(12):e007415. https://doi.org/10.1136/jitc-2023-007415

Article  PubMed  PubMed Central  Google Scholar 

Takamaru H, Yamamoto E, Suzuki H, Nojima M, Maruyama R, Yamano HO, Yoshikawa K, Kimura T, Harada T, Ashida M, Suzuki R, Yamamoto H, Kai M, Tokino T, Sugai T, Imai K, Toyota M, Shinomura Y (2012) Aberrant methylation of RASGRF1 is associated with an epigenetic field defect and increased risk of gastric cancer. Cancer Prev Res 5(10):1203–1212. https://doi.org/10.1158/1940-6207.CAPR-12-0056

Article  Google Scholar 

Tian J, Cui P, Li Y, Yao X, Wu X, Wang Z, Li C (2020) LINC02418 promotes colon cancer progression by suppressing apoptosis via interaction with miR-34b-5p/BCL2 axis. Cancer Cell Int 20:460. https://doi.org/10.1186/s12935-020-01530-2

Article  PubMed  PubMed Central  Google Scholar 

Uppaluri KR, Challa HJ, Gaur A, Jain R, Krishna Vardhani K, Geddam A, Natya K, Aswini K, Palasamudram K, Sri Manjari K (2023) Unlocking the potential of non-coding RNAs in cancer research and therapy. Transl Oncol 35:101730. https://doi.org/10.1016/j.tranon.2023.101730

Article  PubMed  PubMed Central  Google Scholar 

Wang T, Zhai R, Lv X, Wang K, Xu J (2020) LINC02418 promotes malignant behaviors in lung adenocarcinoma cells by sponging miR-4677-3p to upregulate KNL1 expression. BMC Pulm Med 20(1):217. https://doi.org/10.1186/s12890-020-01229-0

Article  PubMed  PubMed Central  Google Scholar 

Xu XH, Sun JM, Chen XF, Zeng XY, Zhou HZ (2022) MicroRNA-494-3p facilitates the progression of bladder cancer by mediating the KLF9/RGS2 axis. Kaohsiung J Med Sci 38(11):1070–1079. https://doi.org/10.1002/kjm2.12588

Article  PubMed  Google Scholar 

Yao F, Huang X, Xie Z, Chen J, Zhang L, Wang Q, Long H, Jiang J, Wu Q (2022) LINC02418 upregulates EPHA2 by competitively sponging miR-372-3p to promote 5-Fu/DDP chemoresistance in colorectal cancer. Carcinogenesis 43(9):895–907. https://doi.org/10.1093/carcin/bgac065

Article  PubMed  PubMed Central  Google Scholar 

Ye Y, Li H, Bian J, Wang L, Wang Y, Huang H (2021) Exploring prognosis-associated biomarkers of estrogen-independent uterine corpus endometrial carcinoma by bioinformatics analysis. Int J Gen Med 14:9067–9081

Article  PubMed  PubMed Central  Google Scholar 

Zhao Y, Du T, Du L, Li P, Li J, Duan W, Wang Y, Wang C (2019) Long noncoding RNA LINC02418 regulates MELK expression by acting as a ceRNA and may serve as a diagnostic marker for colorectal cancer. Cell Death Dis 10(8):568. https://doi.org/10.1038/s41419-019-1804-x

Article